116 related articles for article (PubMed ID: 21955385)
1. Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder.
Rai V
Cell Mol Biol (Noisy-le-grand); 2011 Sep; 57 Suppl():OL1558-66. PubMed ID: 21955385
[TBL] [Abstract][Full Text] [Related]
2. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies.
Zintzaras E
Psychiatr Genet; 2006 Jun; 16(3):105-15. PubMed ID: 16691128
[TBL] [Abstract][Full Text] [Related]
3. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.
Boccia S; Hung R; Ricciardi G; Gianfagna F; Ebert MP; Fang JY; Gao CM; Götze T; Graziano F; Lacasaña-Navarro M; Lin D; López-Carrillo L; Qiao YL; Shen H; Stolzenberg-Solomon R; Takezaki T; Weng YR; Zhang FF; van Duijn CM; Boffetta P; Taioli E
Am J Epidemiol; 2008 Mar; 167(5):505-16. PubMed ID: 18162478
[TBL] [Abstract][Full Text] [Related]
4. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis.
Rubino E; Ferrero M; Rainero I; Binello E; Vaula G; Pinessi L
Cephalalgia; 2009 Aug; 29(8):818-25. PubMed ID: 17714520
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.
Gilbody S; Lewis S; Lightfoot T
Am J Epidemiol; 2007 Jan; 165(1):1-13. PubMed ID: 17074966
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?
Peerbooms OL; van Os J; Drukker M; Kenis G; Hoogveld L; ; de Hert M; Delespaul P; van Winkel R; Rutten BP
Brain Behav Immun; 2011 Nov; 25(8):1530-43. PubMed ID: 21185933
[TBL] [Abstract][Full Text] [Related]
7. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
8. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis.
Pereira TV; Rudnicki M; Pereira AC; Pombo-de-Oliveira MS; Franco RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1956-63. PubMed ID: 17035405
[TBL] [Abstract][Full Text] [Related]
9. MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies.
Li XL; Xu JH
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):244-9. PubMed ID: 22370724
[TBL] [Abstract][Full Text] [Related]
10. Association of 677C>T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia.
Kempisty B; Mostowska A; Górska I; Łuczak M; Czerski P; Szczepankiewicz A; Hauser J; Jagodziński PP
Neurosci Lett; 2006 Jun; 400(3):267-71. PubMed ID: 16545905
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis.
Dong X; Wu J; Liang P; Li J; Yuan L; Liu X
Arch Med Res; 2010 Feb; 41(2):125-33. PubMed ID: 20470942
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to gastric cancer in Chinese populations: a meta-analysis.
Sun L; Sun YH; Wang B; Cao HY; Yu C
Eur J Cancer Prev; 2008 Oct; 17(5):446-52. PubMed ID: 18714187
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
14. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women.
Sazci A; Ergul E; Kucukali I; Kara I; Kaya G
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1113-23. PubMed ID: 16084002
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
Ren A; Wang J
Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A
Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
[TBL] [Abstract][Full Text] [Related]
17. MTHFR C677T polymorphism and osteoporotic fractures.
Valero C; Alonso MA; Zarrabeitia MT; Viadero C; Hernández JL; Riancho JA
Horm Metab Res; 2007 Aug; 39(8):543-7. PubMed ID: 17712717
[TBL] [Abstract][Full Text] [Related]
18. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.
Boccia S; Boffetta P; Brennan P; Ricciardi G; Gianfagna F; Matsuo K; van Duijn CM; Hung RJ
Cancer Lett; 2009 Jan; 273(1):55-61. PubMed ID: 18789576
[TBL] [Abstract][Full Text] [Related]
19. Meta analysis of the association between MTHFR C677T polymorphism and the risk of congenital heart defects.
Yin M; Dong L; Zheng J; Zhang H; Liu J; Xu Z
Ann Hum Genet; 2012 Jan; 76(1):9-16. PubMed ID: 22175539
[TBL] [Abstract][Full Text] [Related]
20. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
Safarinejad MR; Shafiei N; Safarinejad S
Prostate; 2010 Nov; 70(15):1645-57. PubMed ID: 20564317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
